Publications

2024

• Bailey, C., Dalziel, K., Constable, L., Devlin, N., Hiscock, H., Skouteris, H., Peasgood, T. (2024). The performance of the EQ-HWB-S as a measure of quality of life of caregivers in families that have experienced adverse events. The European Journal of Health Economics.
• Huang, L., Devlin, N., Chen, G., Dalziel, K. (2024) A happiness approach to valuing health states for children. Social Science and Medicine.
• Bailey, C., Dalziel, K., Jones, R. et al. The Validity of the EuroQol Health and Wellbeing Short Version (EQ-HWB-S) Instrument in Parents of Children With and Without Health Conditions. PharmacoEconomics (2024). https://doi.org/10.1007/s40273-024-01351-5
• Bailey, C., Deane, D., O’Brien, A., Dalziel, K. (2024) An economic evaluation of point-of-care ultrasound for children presenting to the emergency department with suspected septic arthritis of the hip. Australian Health Review 48, 37-44.
• O’Loughlin, R., Jones, R., Chen, G., Mulhern, B., Hiscock, H., Delvin, N., Dalziel, K. (2024). Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression. PharmacoEconomics. https://doi.org/10.1007/s40273-024-01354-2
• Xiong, X., Carvalho, N., Huang, L., Chen, G., Jones, R., Delvin, N., Mulhern, B., Dalziel, K. (2024). Psychometric Properties of Child Health Utility 9D (CHU9D) Proxy Version Administered to Parents and Caregivers of Children Aged 2–4 Years Compared with Pediatric Quality of Life Inventory™ (PedsQL). PharmacoEconomics. https://doi.org/10.1007/s40273-024-01355-1
• Bailey, C., Howell, M., Raghunandan, R., Dalziel, K., Howard, K., Mulhern, B., Petrou, S., Rowen, D., Salisbury, A., Viney, R., Lancsar, E., & Devlin, N. (2024). The RETRIEVE Checklist for Studies Reporting the Elicitation of Stated Preferences for Child Health-Related Quality of Life. PharmacoEconomics. https://doi.org/10.1007/s40273-023-01333-z
• van Heusden, A., Rivero-Arias, O., Herdman, M., Hiscock, H., Devlin, N., Dalziel, K., & in collaboration with the Quality Of Life in Kids: Key Evidence to Strengthen Decisions in Australia (QUOKKA) Project Team. (2024). Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds. PharmacoEconomics. https://doi.org/10.1007/s40273-024-01350-6
• Rogge A, Snyder C, Liegl G, Rose M, Nolte S, on behalf of the EORTC Quality of Life Group (2024). EORTC QLQ-C30 general population normative data for the United States. Eur J Cancer. https://doi.org/10.1016/j.ejca.2024.114030
• Pilz, M.J., Loth, F.L.C., Nolte, S., Thurner, A.M.M, Gamper, E-M, Anota, A., Liegl, G., Giesinger, J.M., on behalf of the EORTC Quality of Life Group (accepted). General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population. J Patient Rep Outcomes
• Young, T., Velikova, G., Liegl, G., Rose, M., Nolte, S., EORTC Quality of Life Group (in press). EORTC QLQ-C30 normative data for the United Kingdom: Results of a cross-sectional survey of the general population. Eur J Cancer. https://doi.org/10.1016/j.ejca.2024.113927
• Befus, E.G., Mølland, E., Helseth, S., Hagen, M., Stea, T.H., Nolte, S., Haraldstad, K. (2024). The use of youth healthcare services and its association with health-related quality of life, physical and mental health and over-the-counter analgesics use in 13-19-year-old adolescents: a cross-sectional study. BMC Public Health, 24(1), 104. https://doi.org/10.1186/s12889-023-17544-0

2023

• Dalziel, K., van Heusden, A., Sarvananthar, J., Jones, R., McGregor, K., Huang, L., Rivero-Arias, O., Herdman, M., Hiscock, H., & Devlin, N. (2023). A Qualitative Investigation to Develop an Adapted Version of the EQ-5D-Y-3L for Use in Children Aged 2-4 Years. Value in Health, 26(10), 1525–1534. https://doi.org/10.1016/j.jval.2023.06.004
• J. Verstraete, S. Kreimeier, K. Dalziel, B.M. Morrow, J. Jelsma, B. Roudijk, N. Devlin, E. Bidgood, M. Herdman. (2023) PCR245 Stakeholder Engagement and Expert Consultation on the EuroQol Toddler and Infant Populations (EQ-TIPS) Measure of Health-Related Quality of Life (HRQoL). ISPOR Vol 26, Issue 12. https://doi.org/10.1016/j.jval.2023.09.2682
• Huang, L., Dalziel, K., Lloyd, M., Paxton Loke, Adriana C Lozinsky, Mimi Tang. (2023). Cost-effectiveness analysis of probiotic peanut oral immunotherapy (PPOIT) versus placebo in Australian children with peanut allergy alongside a randomised trial. BMJ Open;13:e075521.
• Tew, M., Catchpool, M., Furler, J., De La Rue, K., Clarke, P.,  Manski-Nankervis, J., Dalziel, K. (2023). Site-specific factors associated with clinical trial recruitment efficiency in general practice settings: a comparative descriptive analysis. Trials 24, 164.
• Jones, R., O’Loughlin, R., Xiong, X., Bahrampour, M., Devlin, N., Hiscock, H., Chen, G., Mulhern, B., Dalziel, K. Quality of Life in Kids: Key Evidence to Strengthen Decisions in Australia (QUOKKA) Project Team. Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study. PharmacoEconomics (2023). https://doi.org/10.1007/s40273-023-01330-2
• Xiong, X., Carvalho, N., Huang, L., Chen, G., Jones, R., Devlin, N., Mulhern, B., Dalziel, K., Psychometric properties of Child Health Utility 9D (CHU9D) proxy version administered to parents and caregivers of children aged 2-4 years compared with Pediatric Quality of Life Inventory™ (PedsQL). [accepted]. PharmacoEconomics. 2023
• Jones, R., O’Loughlin, R., Xiong, X., Bahrampour, M., McGregor, K., Yip, S., Devlin, N., Hiscock, H., Mulhern, B., Dalziel, K.. Collecting paediatric health-related quality of life data: Assessing the feasibility and acceptability of the Australian Paediatric Multi-Instrument Comparison (P-MIC) Study. Children 2023;10:1604. doi: https://doi.org/10.3390/children10101604
• Bailey, C., Howell, M., Raghunandan, R., Dalziel, K., Howard, K., Mulhern, B., Stavros, P., Rowen, D., Salisbury, A., Viney, R., Lancsar, E. & Devlin, N. (2023). The RETRIEVE checklist for studies reporting the elicitation of stated preferences for child health related quality of life. PharmacoEconomics.
• Devlin, N. J., Pan, T., Sculpher, M., Jit, M., Stolk, E., Rowen, D.,Norman, R. (2023). Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How? Pharmacoeconomics, doi:10.1007/s40273-023-01300-8
• Mulhern, B. J., Pan, T., Norman, R., Tran-Duy, A., Hanmer, J., Viney, R. & Devlin, N. J. (2023). Understanding the measurement relationship between EQ-5D-5L, PROMIS-29 and PROPr. QUALITY OF LIFE RESEARCH, pp. 14-. doi:10.1007/s11136-023-03462-6
• Chen, C., Bailey, C., Baikie, G., Dalziel, K., & Hua, X. (2023). Parents of children with disability: mental health outcomes and utilisation of mental health services. Disability and Health Journal, https://doi.org/10.1016/j.dhjo.2023.101506
• David-Wilathgamuwa, S., Hu, N., Meyers, T., O’Loughlin, R., Lingam, R. (2023). Socio-emotional and behavioural difficulties in children with chronic physical conditions: Analysis of the Longitudinal Study of Australian Children. Archives of Disease in Childhood 26 April 2023;108:569-575. doi: 10.1136/archdischild-2022-325069
• O’Loughlin, R., Hiscock, H., Devlin, N., Dalziel, K. (2023). Distinct developmental trajectories of health-related quality of life for boys and girls throughout childhood and adolescence; a national level longitudinal study. Health and Quality of Life Outcomes 01 Aug 2023;21(1):82. doi: 10.1186/s12955-023-02171-5
• Xiong, X., Dalziel, K., Huang, L., Mulhern,B., Carvalho, N. (2023). How do common conditions impact health-related quality of life for children? Providing guidance for validating pediatric preference-based measures. Health Qual Life Outcomes. 2023 Jan 25;21(1):8. doi: 10.1186/s12955-023-02091-4.
• Neppelenbroek, N., de Witt, Ardine., Dalziel, K., Devlin, N., Carvalho, N. (2023). Use of utility and disability weights in economics evaluation of pediatric vaccines: a systematic review. Value in Health 2023 Mar 24:S1098-3015(23)00103-1. doi: 10.1016/j.jval.2023.03.005.
• Tew, M., Catchpool, M., Furler, J., De La Rue, K., Clarke, P., Manski-Nankervis, J.A., Dalziel, K. (2023).  Site-specific factors associated with clinical trial recruitment efficiency in general practice settings: a comparative descriptive analysis. Trials. 2023 Dec;24(1):1-8.
• Hua, X., Rivero-Arias, O., Quigley, M.A., Kurinczuk, J.J., Carson, C. (2023). Long-term healthcare utilization and costs of babies born after assisted reproductive technologies (ART): a record linkage study with 10-years’ follow-up in England. Human Reproduction. 2023 Dec 1;38(12):2507-15.
• Hua, X., Petrou, S., Coathup, V., Carson, C., Kurinczuk, J.J., Quigley, M.A., Boyle, E., Johnson, S., Macfarlane, A., Rivero-Arias, O. (2023). Gestational age and hospital admission costs from birth to childhood: a population-based record linkage study in England. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2023 Sep 1;108(5):485-91.
• Chen, W., Sun, L., Pan, T., Bai, G. (2023). Health-related quality of life of children with Williams Syndrome and caregivers in China. Front. Public Health Sec. Children and Health Volume 11 - 2023 | doi: 10.3389/fpubh.2023.1177317
• de Ligt, K.M., Aaronson, N.K., Liegl, G., Nolte, S. (2023). Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study. Qual Life Res. https://doi.org/10.1007/s11136-023-03404-2
• Johansson, H., Lagergren, P., Nolte, S., Brandberg, Y. (2023). Comparison between Swedish EORTC QLQ-C30 general population norm data published in 2000 and 2019. Acta Oncol, 1-7. https://doi.org/10.1080/0284186x.2023.2271165
• Pilz, M.J., Nolte, S., Liegl, G., King, M., Norman, R., McTaggart-Cowan, H., Bottomley, A., Rose, M., Kemmler, G., Holzner, B., Gamper,E.M., EORTC Quality of Life Group (2023). The European Organisation for Research and Treatment of Cancer Quality of Life Utility-Core 10 Dimensions: Development and Investigation of General Population Utility Norms for Canada, France, Germany, Italy, Poland, and the United Kingdom. Value Health. , 26(5):760–7, https://doi.org/10.1016/j.jval.2022.12.009
• Potashman, M., Pang, M., Tahir,M., Shahraz, S., Dichter, S., Perneczky, R., Nolte, S. (2023). Psychometric properties of the Alzheimer's Disease Cooperative Study - Activities of Daily Living for Mild Cognitive Impairment (ADCS-MCI-ADL) scale: a post hoc analysis of the ADCS ADC-008 trial. BMC Geriatr, 23(1), 124. https://doi.org/10.1186/s12877-022-03527-0.
• Wagner C, Witt JH, Nolte S, van der Poel HG, Aaronson NK, Kolvatzis M, Tian Z, Mendrek M, Liakos N, Gratzke C, Leyh-Bannurah S-R (2023). Differences in Quality of Life between German and Dutch Patients with Prostate Cancer Treated with Robot-assisted Radical Prostatectomy: Implications for International Multicenter Randomized Controlled Trials. Eur Urol Focus. https://doi.org/10.1016/j.euf.2023.02.007

2022 and earlier

• Jones, R., Hiscock, H., Shanthikumar, S., Lei, S., Sanci,L., Chen, K. (2022). Exploring gaps and opportunities in primary care following an asthma hospital admission: a multisite mixed-methods study of three data sources. Archives of Disease in Childhood. Published Online First: 04 January 2023. doi: 10.1136/archdischild-2022-324114
• Chen, K.Y., Jones, R., Lei, S., Shanthikumar, S., Sanci, L., Carlin, J., Hiscock, H. (2022). Primary health care utilization and hospital readmission in children with asthma: A multi-site linked data cohort study. J Asthma 2023:1-12. Published Online First: 2023/01/04. doi: 10.1080/02770903.2022.2164200
• Hua X, Dalziel K, Brettig T, Dharmage SC, Lowe A, Perrett KP, Peters RL, Ponsonby AL, Tang ML, Koplin J. Out‐of‐hospital health care costs of childhood food allergy in Australia: A population‐based longitudinal study. Pediatric Allergy and Immunology. 2022 Nov;33(11):e13883.
• Ride J, Cameron L, Jones R, Dalziel K, Wurzel D, Kao K-T, et al. (2022). Preferences of parents for mental health services to suit children with chronic medical conditions. Australian Health Review. 2022.
• Gillespie, A.N., Dalziel, K., Webb,E., Wong,J., Jones, C.A., Sung, V.; on behalf of the HearS-cCMV Project † .  (2022). Targeted screening for congenital cytomegalovirus: A micro-costing analysis. Journal of Paedatrics and Child Health. 21 September 2022.
• Khano,S., Sanci, L., Woolfenden, S., Zurynski, Y., Dalziel, K., Liaw, S., Boyle,D., Freed, G.L., Moore,C., Hodgins, M., Le, J., Morris, T.M., Germano, S., Wheeler, K., Lingam, R., Hiscock, H. (2022). Strengthening Care for Children (SC4C): protocol for a stepped wedge cluster randomised controlled trial of an integrated general practitionerpaediatrician model of primary care. BMJ Open, 2022; 12 e063449.
• Brettig, T., Dalziel, K., Koplin, J.J., Dang, T., Lange, L., McWilliam, V., Sato, S., Savvatianos, S., Perrett, K.P. Ana o 3 sIgE and diagnostic algorithms reduce cost of cashew allergy diagnosis in children compared with skin prick test: A cost comparison analysis. Pediatric Allergy and Immunology. 33(8), August 2022.
• Bailey, C., Howell, M., Raghunandan, R., Salisbury, A., Chen G., Coast, J., Craig, J. Devlin, N., Huynh, E., Lancsar, E., Mulhern, B., Norman, R., Petrou, S., Ratcliffe, J., Street, D., Howard, K., and Viney, R (2022). Preference Elicitation Techniques Used in Valuing Children’s Health‑Related Quality‑of‑Life: A Systematic Review PharmacoEconomics https://doi.org/10.1007/s40273-022-01149-3
• Devlin, N., Pan, T., Kreimeier, S. et al. (2022). Valuing EQ-5D-Y: the current state of play. Health Qual Life Outcomes 20, 105. https://doi.org/10.1186/s12955-022-01998-8
• O’Loughlin, R., Hiscock, H., Pan, T., Devlin, N., Dalziel. K. (2022). The relationship between physical and mental health multimorbidity and children’s health-related quality of life. Qual Life Res 31, 2119–2131 (2022). https://doi.org/10.1007/s11136-022-03095-1
• Shi, Y.C, Hiscock, H, Oakley, E,. Freed, G., O’Loughlin, R. (2022). Non-indicated brain computed tomography scans for children: adaptation of an American measurement tool and contrast of current practice in an Australian Hospital. Pediatric Emergency Care 2022 Feb 1;38(2):e550-5. doi: 10.1097/PEC.0000000000002515
• Amin, S., Joo, S., Nolte, S., Yoo, H.K., Patel, N., Byrnes, H.F., Costa-Cabral, S., Johnson, C.D,. (2022). Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values. BMC Cancer, 22(1), 563. https://doi.org/10.1186/s12885-022-09661-7
• Elsworth, G., Nolte, S., Cheng, C., Hawkins, M., Osborne, R. (2022). Modelling variance in the multi-dimensional Health Literacy Questionnaire: Does a General Health Literacy factor account for observed interscale correlations? SAGE Open Med, 10, https://doi.org/10.1177/2050312122112471
• Liegl, G., Obbarius, A., Rose, M., Fischer, K.I., Stengel, A., Knebel, F., Buttgereit, F., Nolte, S. (2022). Frequently used patient-reported outcome (PRO) measures of general physical function were highly correlated with the physical performance test, a multi-task performance outcome (PerfO) measure. Value Health. https://doi.org/10.1016/j.jval.2022.05.008
• Osborne, R.H., Cheng, C.C., Nolte, S., Elmer, S., Besançon, S., Budhathoki, S.S., Debussche, X., Dias, S., Kolarčik, P., Loureiro, M.I., Maindal, H., do Ó,D.M., Smith, J.A., Wahl, A., Elsworth, G.R., Hawkins, M. (2022). Health literacy measurement: embracing diversity in a strengths-based approach to promote health and equity, and avoid epistemic injustice. BMJ Global Health. http://dx.doi.org/10.1136/bmjgh-2022-009623
• Pilz, M.J., Gamper, E-M., Efficace, F., Arraras, J.I., Nolte, S., Liegl, G., Rose, M., Giesinger, J.M.; EORTC Quality of Life Group (2022). EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: An analysis of 1,036 individuals. BMC Public Health, 22(1), 1040. https://doi.org/10.1186/s12889-022-13211-y

2026

• Santos Gonzalez F, Martin E, Harris M, Casauria S, The Australian Undiagnosed Disease Network, Christodoulou J, Goranitis I. The value of functional genomics: a contingent valuation. Expert Rev Pharmacoecon Outcomes Res. 2026 Feb;26(2):195-202.
• Liu C, Best S, Fatkin D, Goranitis I. Societal Preferences, Values and Priorities for Genomic Testing for Atrial Fibrillation: Evidence from Two Discrete Choice Experiments. Patient. 2026 Feb 13.
• Fehlberg Z, Liu C, Kugenthiran N, Fatkin D, Goranitis I, Best S. Gauging Patient- and Family-Perceived Value of Genetic Testing for Atrial Fibrillation. Heart, Lung and Circulation. 2026;35(3):e29-e31.

2025

• Rius R, Compton AG, … Goranitis I, … Thorburn DR. The Australian Genomics Mitochondrial Flagship: A national program delivering mitochondrial diagnoses. Genetics in Medicine. 2025;27(1).
• Fehlberg, Z., Fisher, L., Liu, C., Kugenthiran, N., Milne, R. L., Young, M. A., ... & Best, S. (2025). Using a behaviour-change approach to support uptake of population genomic screening and management options for breast or prostate cancer. European Journal of Human Genetics, 33(1), 108-120.
• Kelada L, Best S, Pierce K, … Goranitis I, … Howell KB. Fulfilling the needs of caregivers in delivering health services to children with developmental and epileptic encephalopathies. European Journal of Paediatric Neurology. 2025;54:147-58.
• Santos Gonzalez F, Ungar WJ, … Goranitis I. Microcosting genomics: Challenges and opportunities. Genetics in Medicine. 2025;27(2).
• Goranitis I, Sheen D, Fehlberg Z, Mallett AJ, Best S, Stark Z. A Standardized Measurement and Valuation Scale of Genomic Utility for Policy Decisions: The GUV Scale. Value in Health. 2025;28(2):184-90.
• Schilling C, Sjaaf F, Goranitis I, …, Gaff C. Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023. European Journal of Human Genetics. 2025.
• Best S, Braithwaite J, Goranitis I, ... Using implementation science to navigate the complexity of integrating genomics into healthcare. Nature Medicine. 2025.
• Bourke M, McInerney-Leo A, …, Goranitis I. The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature Review. Applied Health Economics and Health Policy. 2025.
• Buchanan J, Goranitis I, Weymann D. The Health Economics of Genomic Technologies: A Growing Evidence Base on Value. Appl Health Econ Health Policy. 2025;23(3):331-5.
• Smith HS, Buchanan J, Goranitis I, et al. Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity. Value in Health. 2025;28(8):1213-20
• Smith HS, Regier DA, Goranitis I, … Marshall DA. Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework. Applied Health Economics and Health Policy. 2025.
• Peters R, Best S...Goranitis I. Public preferences for the value and implementation of genomic newborn screening: Insights from two discrete choice experiments in Australia. The American Journal of Human Genetics.
• Pan T, Trajanovska M... Goranitis I. Psychometric comparison of CHU9D and PedsQL 4.0 proxy version administered to parents of children with congenital colorectal conditions in Australia. The European Journal of Health Economics. 2025
  DeBortoli E, McGahan E, Yanes T, Berkman J, Aoude LG, Smit AK, et al. Utility of Germline, Somatic and ctDNA Testing in Adults With Cancer. Cancer Medicine. 2025;14(15):e71080.
• Lunke S, Downie L, Caruana J, Kugenthiran N, De Fazio P, Hollizeck S, ... Goranitis I...et al. Feasibility, acceptability and clinical outcomes of the BabyScreen+ genomic newborn screening study. Nature Medicine. 2025.
  Sheen D, Willis A, Fehlberg Z, .. Gorantis I, MA Young. Systematic review of preferences for additional findings from genomic testing. Eur J Hum Genet. 2025
• Goranitis I, Hayeems RZ, Smith HS, Buchanan J, Weymann D, Regier DA, et al. Determining the value of genomics in healthcare. Nature Medicine. 2025.
• Pan T, Trajanoversuska M, Meng Y, Best S, King SK, Goranitis I. Public Preferences and Willingness to Pay for a Multidisciplinary Colorectal and Pelvic Reconstruction Service. The Patient - Patient-Centered Outcomes Research. 2025.

2024

• Eratne D, Kang MJY, Lewis C, Dang C, Malpas C, Ooi S, et al. Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disorders. Journal of the Neurological Sciences. 2024;467:123291.
• Park K, Chen M, Malijan GM, Song D, Ross AL, Ambrosino E, et al. Accelerating access to human genomics for public health: perspectives from the Western Pacific region. The Lancet Regional Health - Western Pacific. 2024;53.
• Santos Gonzalez F, Hock DH, Thorburn DR, Mordaunt D, Williamson NA, Ang CS... Goranitis I. A micro-costing study of mass-spectrometry based quantitative proteomics testing applied to the diagnostic pipeline of mitochondrial and other rare disorders. Orphanet Journal of Rare Diseases. 2024;19(1).
• Best S, Fehlberg Z, Richards C, Quinn MCJ, Lunke S, Spurdle AB, et al. Reanalysis of genomic data in rare disease: current practice and attitudes among Australian clinical and laboratory genetics services. European Journal of Human Genetics. 2024;32(11):1428-35.
• Ride J, Goranitis I, Meng Y, LaBond C, Lancsar E. A Reporting Checklist for Discrete Choice Experiments in Health: The DIRECT Checklist. PharmacoEconomics. 2024;42(10):1161-75.
• Mallawaarachchi A, Biros E, Harris T, Bennetts B, Boughtwood T, Elliott J, et al. Shaping the future of kidney genetics in Australia: proceedings from the KidGen policy implementation workshop 2023. Human Genomics. 2024;18(1).
• Williams EV, Goranitis I, Oppong R, Perry SJ, Devall AJ, Martin JT, et al. A cost-effectiveness analysis of early detection and bundled treatment of postpartum hemorrhage alongside the E-MOTIVE trial. Nature Medicine. 2024;30(8):2343-8.
• Fehlberg Z, Goranitis I, Mallett AJ, Stark Z, Best S. Determining priority indicators of utility for genomic testing in rare disease: A Delphi study. Genetics in Medicine. 2024;26(6).
• Lynch F, Best S, Gaff C, Downie L, Archibald AD, Gyngell C, et al. Australian public perspectives on genomic newborn screening: which conditions should be included? Human Genomics. 2024;18(1).
• Marshall DA, Hua N, Buchanan J, Christensen KD, Frederix GWJ, Goranitis I, et al. Paving the path for implementation of clinical genomic sequencing globally: Are we ready? Health Aff Sch. 2024;2(5):qxae053.
• Lunke S, Bouffler SE, Downie L, Caruana J, Amor DJ, Archibald A, et al. Prospective cohort study of genomic newborn screening: BabyScreen+ pilot study protocol. BMJ Open. 2024;14(4).
• Meng Y, Best S, Amor DJ, Braden R, Morgan AT, Goranitis I. The value of genomic testing in severe childhood speech disorders. European Journal of Human Genetics. 2024;32(4):440-7.
• Mordaunt DA, Gonzalez FS, Lunke S, Eggers S, Sadedin S, Chong B,… Goranitis I. The cost of proband and trio exome and genome analysis in rare disease: A micro-costing study. Genetics in Medicine. 2024;26(4).
• Lynch F, Meng Y, Best S, Goranitis I, Savulescu J, Gyngell C, Vears DF. Australian public perspectives on genomic data governance: responsibility, regulation, and logistical considerations. European Journal of Human Genetics. 2024;32(3):295-301.
• Goranitis I, Meng Y, Martyn M, Best S, Bouffler S, Bombard Y, et al. Eliciting parental preferences and values for the return of additional findings from genomic sequencing. npj Genomic Medicine. 2024;9(1).
• Robertson EG, Kelada L, Best S, Goranitis I, Pierce K, Roberts NJ, et al. Quality of life in caregivers of a child with a developmental and epileptic encephalopathy. Developmental Medicine and Child Neurology. 2024;66(2):206-15.
• Lynch F, Best S, Gaff C, Downie L, Archibald AD, Gyngell C, et al. Australian Public Perspectives on Genomic Newborn Screening: Risks, Benefits, and Preferences for Implementation. International Journal of Neonatal Screening. 2024;10(1).
• Khorshidi HA, Marshall D, Goranitis I, Schroeder B, Ijzerman M. System dynamics simulation for evaluating implementation strategies of genomic sequencing: tutorial and conceptual model. Expert Review of Pharmacoeconomics and Outcomes Research. 2024;24(1):37-47.
• Mallett AJ, Ingles J, Goranitis I, Stark Z. Implementation of reimbursement for genomic testing in Australia: early successes and the pathway ahead. Internal Medicine Journal. 2024;54(4):531-4.
• Wu Y, Jayasinghe K, Stark Z, Quinlan C, Patel C, McCarthy H, et al. Response to Lombardi and Mesnard. Genetics in Medicine. 2024;26(1).
• Jayasinghe K, Biros E, Harris T, Wood A, O'Shea R, Hill L, et al. Implementation and Evaluation of a National Multidisciplinary Kidney Genetics Clinic Network Over 10 Years. Kidney International Reports. 2024;9(8):2372-85.

2023

• Santos Gonzalez F, Mordaunt D, Stark Z, Dalziel K, Christodoulou J, Goranitis I. Microcosting diagnostic genomic sequencing: A systematic review. Genet Med. 2023 Mar 16;25(6):100829. doi: 10.1016/j.gim.2023.100829.
• Lynch F, Meng Y, Best S, Goranitis I, Savulescu J, Gyngell C, Vears DF. Australian public perspectives on genomic data governance: responsibility, regulation, and logistical considerations. European Journal of Human Genetics. 2023 May 10. Doi: 10.1038/s41431-023-01381-
• Robertson EG, Kelada L, Best S, Goranitis I, Pierce K, CoGENeS Group*, Bye A, Palmer EE . Quality of life in caregivers of a child with a developmental and epileptic encephalopathy. Dev Med Child Neurol. 2023 Jul 08; 00:1– 10. Doi: https://doi.org/10.1111/dmcn.15695
• Mordaunt DA, Dalziel K, Goranitis I, Stark Z. Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia. European Journal of Human Genetics. 2023 July 03. Doi: https://doi.org/10.1038/s41431-023-01417-6
• McLoughlin C, Goranitis I, Al Janabi H. The feasibility and validity of preference-based quality of life measures with informal carers: a think-alouid study. Vallue in Health. 2023 Jul 27. Doi: https://doi.org/10.1016/j.jval.2023.07.002
• Sheen D, Peasgood T, Goranitis I. Eliciting Societal Preferences for Non-Health Outcomes: A Person Trade-Off Study in the COntext of Genomics. Clinical Therapeutics. 2023 Jul 29. Doi: https://doi.org/10.1016/j.clinthera.2023.07.004
• Wu Y, Jayasinghe K, Stark Z, Quinlan C, Patel C, McCarthy H, Mallawaarachchi AC, Mallett AJ, Goranitis I. Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation. Genetics in Medicine. 2023 Jul 21. Doi: https://doi.org/10.1016/j.gim.2023.100942
• Khorshidi, H. A., Marshall, D., Goranitis, I., Schroeder, B. & Ijzerman, M. (2024). System dynamics simulation for evaluating implementation strategies of genomic sequencing: tutorial and conceptual model. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 24(1), pp. 37-47. doi:10.1080/14737167.2023.2267764
• Robertson, E. G., Roberts, N. J., Le Marne, F., Beavis, E., ...Goranitis I.,... Palmer, E. E. (2023). "Somewhere to turn to with my questions": A pre-post pilot of an information linker service for caregivers who have a child with a Developmental and Epileptic Encephalopathy. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 47 pp. 94-104. doi:10.1016/j.ejpn.2023.09.010
• Mallett A, Stark Z, Fehlberg Z, Best S, Goranitis I. Determining the utility of diagnostic genomics: a conceptual framework. Human Genomics. 2023 Aug 16. Doi: https://doi.org/10.1186/s40246-023-00524-1
• Mordaunt DA, Stark Z, Santos Gonzalez F, Dalziel, K, Goranitis I. Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia BMJ Open 2023;13:e069441. doi: 10.1136/bmjopen-2022-069441
• Pan, T Wu Y, Buchanan J, Goranitis I. QALYs and rare diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia. Health Qual Life Outcomes. 2023. 21, 132. https://doi.org/10.1186/s12955-023-02216-9
• Zhou Y, Shadbolt C, Thuraisingam S, Schilling C, Choong P, Dowsey M Differences in Outcomes Between Initial Responders and Subsequent Responders to Health Questionnaires for Total Hip and Knee Arthroplasty: An Australian Tertiary Institutional Registry Study. JOURNAL OF ARTHROPLASTY. 2023; 38(12): 2561-2567. doi:10.1016/j.arth.2023.05.079
• Zhou Y, Frampton C, Dowsey M, Choong P, Schilling C, Hirner M Assessing the Mortality Rate After Primary Total Knee Arthroplasty: An Observational Study to Inform Future Economic Analysis. JOURNAL OF ARTHROPLASTY. 2023; 38(11): 11-. doi:10.1016/j.arth.2023.05.070
• Schilling C, Tew M, Bunzli S, Shadbolt C, Lohmander L, Balogh Z, Paolucci F, Choong P, Dowsey M, Clarke P An Economic Model for Estimating Trial Costs with an Application to Placebo Surgery Trials. APPLIED HEALTH ECONOMICS AND HEALTH POLICY. 2023; 21(2): 263-273. doi:10.1007/s40258-022-00775-4
• Zhou Y, Dowsey M, Spelman T, Choong P, Schilling C DEVELOPING AND EVALUATING THE SMART CHOICE (KNEE): A PATIENT-FOCUSED TOOL TO PREDICT HEALTH-RELATED QUALITY OF LIFE OUTCOMES AFTER TOTAL KNEE ARTHROPLASTY. Orthopaedic Proceedings. 2023; 105-B(SUPP_3): 118-118. doi:10.1302/1358-992x.2023.3.118
• Zhou Y, Shadbolt C, Rele S, Spelman T, Dowsey M, Choong P, Schilling C CALCULATING AND COMPARING THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE FOR VETERANS RAND 12 UTILITY SCORE IN TOTAL KNEE ARTHROPLASTY. Orthopaedic Proceedings. 2023; 105-B(SUPP_3): 117-117. doi:10.1302/1358-992x.2023.3.117
• Kuek T, Schilling C, Choong P The impact of cost on quality of surgical management in non-metastatic extremity sarcoma: A cross-country narrative literature review with a systematic approach. JOURNAL OF ORTHOPAEDIC SURGERY. 2023; 31(1): 10-. doi:10.1177/10225536231168989
• Gorniak M, Pardillo M, Keating C, Brown C, Schilling C Net cost savings arising from patient completion of an active self-management program.. PLoS One. 2023; 18(11): e0293352-. doi:10.1371/journal.pone.0293352
• Peasgood T, Bourke M, Devlin N, Rowen D, Yang Y, Dalziel K Randomised comparison of online interviews versus face-to-face interviews to value health states. SOCIAL SCIENCE & MEDICINE. 2023; 323: 11-. doi:10.1016/j.socscimed.2023.115818
• Xiong X, Huang L, Herd DW, et al. Cost-effectiveness of prednisolone to treat Bell Palsy in children: an economic evaluation alongside a randomized controlled trial. Neurology. 2023;100(24):e2432-e2441.
• Xiong, X., Dalziel, K., Huang, L. et al. How do common conditions impact health-related quality of life for children? Providing guidance for validating pediatric preference-based measures. Health Qual Life Outcomes 21, 8 (2023). https://doi.org/10.1186/s12955-023-02091-4
• Xiong X, Dalziel K, Huang L, Rivero-Arias O. Test-Retest Reliability of EQ-5D-Y-3L Best-Worst Scaling Choices of Adolescents and Adults,Value in Health,Volume 26, Issue 1,2023
• Palladino R*, Pan T*, Mercer SW, Atun R, McPake B, Rubba F, Triassi M, Lee JT (2023). Multimorbidity and out-of-pocket expenditure on medicine in Europe: Longitudinal analysis of 13 European countries between 2013 and 2015. Front Public Health. 2023 Jan 5;10:1053515.1–12.
• Zhang X, Pan T, McPake B (2023). Re-examining the reversal hypothesis: A nationwide population-based study of the association between socioeconomic status, and NCDs and risk factors in China. SSM - Population Health, 21, 2023, 101335, 1–12.
• Ishida, M., D’Souza, M., Zhao, Y., Pan, T., Carman, W., Haregu, T., Lee, TJ (2023). The association between obesity, health service use, and work productivity in Australia- a cross-sectional quantile regression analysis. Sci Rep 13, 6696, 1–9. (2023).
• Mulhern B, Pan T, Norman R, Tran-Duy A, Hanmer J, Viney R, Devlin N Understanding the measurement relationship between EQ-5D-5L, PROMIS-29 and PROPr. QUALITY OF LIFE RESEARCH. 2023; 32(11): 3147-3160. doi:10.1007/s11136-023-03462-6
• Devlin N, Pan T, Sculpher M, Jit M, Stolk E, Rowen D, Van Hout B, Norman R Using Age-Specific Values for Pediatric HRQoL in a Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?. PHARMACOECONOMICS. 2023; 41(10): 1165-1174. doi:10.1007/s40273-023-01300-8

2022

• Robertson E, Kelada L, Best S, Goranitis I, Grainger N, Le Marne F, Pierce K, Nevin S, Macintosh R, Beavis E, Sachdev R, et al. Acceptability and feasibility of an online information linker service for caregivers who have a child with genetic epilepsy: a mixed-method pilot study protocol. BMJ OPEN. 2022; 12(10): 10-. doi:10.1136/bmjopen-2022-063249
• Buchanan J, Goranitis I, Slade I, Kerasidou A, Sheehan M, Sideri K, Wordsworth S Resource allocation in genetic and genomic medicine.. J Community Genet. 2022; 13(5): 463-466. doi:10.1007/s12687-022-00608-w
• Goranitis I Health policy making under information constraints: An evaluation of the policy responses to the economic crisis in Greece (vol 117, pg 279, 2014). HEALTH POLICY. 2022; 126(7): 722-722.
• Wu Y, Balasubramaniam S, Rius R, Thorburn D, Christodoulou J, Goranitis I Genomic sequencing for the diagnosis of childhood mitochondrial disorders: a health economic evaluation. EUROPEAN JOURNAL OF HUMAN GENETICS. 2022; 30(5): 577-586. doi:10.1038/s41431-021-00916-8
• Goranitis I, Wu Y, Lunke S, White S, Tan T, Yeung A, Hunter M, Martyn M, Gaff C, Stark Z Is faster better? An economic evaluation of rapid and ultra-rapid genomic testing in critically ill infants and children. GENETICS IN MEDICINE. 2022; 24(5): 1037-1044. doi:10.1016/j.gim.2022.01.013
• Meng Y, Clarke P, Goranitis I The Value of Genomic Testing: A Contingent Valuation Across Six Child- and Adult-Onset Genetic Conditions. Pharmacoeconomics. 2022; 40(2): doi:10.1007/s40273-021-01103-9
• Datt G, Liu C, Smyth R Missing Women in China and India over Seven Decades: An Analysis of Birth and Mortality Data from 1950 to 2020. JOURNAL OF DEVELOPMENT STUDIES. 2022; 58(9): 1807-1830. doi:10.1080/00220388.2022.2055466
• Mar V, Liu W, Liu C, Mcarthur G, Wolfe R, Kelly J Growth Rate and Survival; the Insidious Progression of BRAF Mutant Melanomas. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2013; 11: 11-11.
• Xiong, X., Dalziel, K., Carvalho, N. et al. Association between 24-hour movement behaviors and health-related quality of life in children. Qual Life Res 31, 231–240 (2022). https://doi.org/10.1007/s11136-021-02901-6
• Pan, T., Anindya, K., Devlin, N. et al (2022). The impact of depression and physical multimorbidity on health-related quality of life in China: a national longitudinal quantile regression study Sci Rep. 12, 21620, 1–9 (2022).
• Devlin, N., Pan, T., Kreimeier, S., Verstraete, J., Stolk, E., Rand, K., Herdman, M (2022). Health Qual Life Outcomes. 20, 105, 1–11 (2022).
• Pan, T., Mulhern, B., Viney, R., Norman, R., Hanmer, J., Devlin, N. (2022). A comparison of PROPr and EQ-5D-5L value sets. PharmacoEconomics. 40, 297–307 (2022).
• O’Loughlin R, Hiscock H, Pan T, Devlin N, Dalziel K. The relationship between physical and mental health multimorbidity and children’s health-related quality of life. (2022). Qual Life Res. 31, 2119–2131 (2022).
• Pan, T., Mulhern, B., Viney, R., Norman, R., Tran-Duy, A., Hanmer, J., Devlin, N. (2022). Evidence on the relationship between PROMIS-29 and EQ-5D: A Literature Review. Qual Life Res. 31, 79–89. (2022).

2021 and earlier

• Bunzli S, Choong E, Shadbolt C, Wall L, Nelson E, Schilling C, Wilding H, Lohmander L, Balogh Z, Paolucci F, Clarke P, et al. Placebo Surgery Controlled Trials Do They Achieve What They Set Out To Do? A Systematic Review. ANNALS OF SURGERY. 2021; 273(6): 1102-1107. doi:10.1097/SLA.0000000000004719
• Bunzli S, Nelson E, Wall L, Schilling C, Lohmander L, Balogh Z, Tran P, Paolucci F, Clarke P, Choong P, Dowsey M, et al. Factors Underlying Patient and Surgeon Willingness to Participate in a Placebo Surgery Controlled trial: A Qualitative Investigation.. Ann Surg Open. 2021; 2(4): e104-. doi:10.1097/AS9.0000000000000104
• Baker D, Dennis M, Zannino D, Schilling C, Moreno P, Bullock A, Disney P, Radford D, Hornung T, Grigg L, D'Udekem Y, et al. Path ahead for 'low risk' adolescents living with a Fontan circulation. HEART. 2021; 107(7): 556-+. doi:10.1136/heartjnl-2020-317619
• Butterworth P, De New S, Schilling C, Saxby K, Petrie D, Wong C Dynamics of Mental Health and Healthcare Use among Children and Young Adults. AUSTRALIAN ECONOMIC REVIEW. 2021; 54(1): 130-146. doi:10.1111/1467-8462.12413
• Rele S, Shadbolt C, Schilling C, Taylor N, Dowsey M, Choong P The Impact of Enhanced Recovery After Surgery on Total Joint Arthroplasty: Protocol for a Systematic Review and Meta-analysis. JMIR RESEARCH PROTOCOLS. 2021; 10(3): 8-. doi:10.2196/25581
• Trieu J, Schilling C, Dowsey M, Choong P The cost-effectiveness of computer navigation in primary total knee replacement: a scoping review. EFORT OPEN REVIEWS. 2021; 6(3): 173-180. doi:10.1302/2058-5241.6.200073
• Anindya K, Ng N, Atun R, Marthias T, Zhao Y, Mcpake B, Van Heusden A, Pan T, Lee J Effect of multimorbidity on utilisation and out-of-pocket expenditure in Indonesia: quantile regression analysis. BMC HEALTH SERVICES RESEARCH. 2021; 21(1): 12-. doi:10.1186/s12913-021-06446-9
• Pan T, Mercer S, Zhao Y, Mcpake B, Desloge A, Atun R, Hulse E, Lee J The association between mental-physical multimorbidity and disability, work productivity, and social participation in China: a panel data analysis. BMC PUBLIC HEALTH. 2021; 21(1): 13-. doi:10.1186/s12889-021-10414-7
• Zhao Y, Atun R, Anindya K, Mcpake B, Marthias T, Pan T, Van Heusden A, Zhang P, Duolikun N, Lee J Medical costs and out-of-pocket expenditures associated with multimorbidity in China: quantile regression analysis. BMJ GLOBAL HEALTH. 2021; 6(2): 10-. doi:10.1136/bmjgh-2020-004042
• Goranitis I, Best S, Christodoulou J, Boughtwood T, Stark Z Preferences and values for rapid genomic testing in critically ill infants and children: a discrete choice experiment. EUROPEAN JOURNAL OF HUMAN GENETICS. 2021; 29(11): 1645-1653. doi:10.1038/s41431-021-00874-1
• Jayasinghe K, Wu Y, Stark Z, Kerr P, Mallett A, Gaff C, Martyn M, Goranitis I, Quinlan C Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases. KIDNEY INTERNATIONAL REPORTS. 2021; 6(11): 2850-2861. doi:10.1016/j.ekir.2021.08.028
• Goranitis I, Best S, Stark Z, Boughtwood T, Christodoulou J The value of genomic sequencing in complex pediatric neurological disorders: a discrete choice experiment. GENETICS IN MEDICINE. 2021; 23(1): 155-162. doi:10.1038/s41436-020-00949-2
• Hall J, Goranitis I, Kigozi J, Guariglia A New evidence on the impact of the Great Recession on health-compromising behaviours. ECONOMICS & HUMAN BIOLOGY. 2021; 41: 9-. doi:10.1016/j.ehb.2021.100980

2026

• Abraham P, Lubis IN, Novivanti R, Trianty L, Nisa FA, Kariodimedjo P, Amalia R, Cahyadi RA, Al Qorny TM, Perlambang YA, Permatasari R. The household economic burden of human-only and zoonotic malaria, compared to other causes of acute febrile illness in Indonesia. BMJ Global Health. 2026 Mar 26;11(3). https://doi.org/10.1136/bmjgh-2025-020504
• Quach A, Mayxay M, Bounvilay L, Thammavong A, Bounkhoun T, Phaiphichit C, Kingkeooudom N, Phangmanixay S, Souvannasing P,  Ashley EA, Nguyen C, Carvalho N*, Russell FM* (*Joint senior) Financial burden of severe childhood illness on households in Lao People’s Democratic Republic: A prospective cohort study. PLOS Global Public Health. 2026; 6(2): e0004783. https://doi.org/10.1371/journal.pgph.0004783
• Niyibitegeka F, Manirakiza A, Hezagira N, Sinarinzi P, Abraham P, Devine A. Economic burden of malaria in children under the age of five in Burundi. Malar J. 2025;25(1):11. https://doi.org/10.1186/s12936-025-05684-0
• Dysoley L, Cassidy-Seyoum S, Adhikari B, Dahal A, Solana T, Phoumen N, Srey S, Phalla T,  Vonn P, Engrkruy B, Sovanarath O, Mengkea H, Rathana P, Makara I, Suor B, Heng PK, Heng Y, Khlok H, Pong K, Moeng T, Soviet U, Ravuth R, Bunreth V, Vannak K, Sokhann M, Kimmen K, Dy K, Samol S, Lo K, Sokunthea N, Kry H, Kanha L, Naren L, Oum S, Sovann YK, Channavuth R,  Bunmeng C, Hughes J, Brindle H, Hu Y, Peng S, Mardi P, Chanry I, Preap S, Heoy S, Sabawoon F, Sokha T, Ringwald P, Lynch CA, Price RN, Tripura R, von Seidlein L, Devine A, Thriemer K. Moving towards high-dose primaquine or tafenoquine for P. vivax treatment in Cambodia: A meeting report from dissemination of results of the EFFORT trial to stakeholders. Malaria Journal. 2026; 25:2, 1-9. https://doi.org/10.1186/s12936-025-05691-1
• Carlin JB, Marcato AJ, Wang Y, Moss R, Carville KS, Chen X, Oliver VL, Spirkoska V, Campbell PT, Price DJ, Carvalho N. Cost-effectiveness of immunising interventions to reduce respiratory syncytial virus disease burden in infants in Australia. PharmacoEconomics. 2026. https://doi.org/10.1007/s40273-026-01601-8
• Cheng Q, Watts C, Al Adawiyah R, Guy R, Ong JJ, Bradshaw CS, Wiseman V. Cost of illness of Mycoplasma genitalium in Australia: an incidence-based approach incorporating resistance-guided therapy. Sci Rep. 2026. https://doi.org/10.1038/s41598-026-36992-3
• Carvalho N, Watts E, Oliver V L, Clark A, Ozturk MH, Akauola S, Whelan C, Naseri T, Jenkins K, Mikkelsen-Lopez I, Lam KFK, Rabanal R, McLeod R, Jit M, & Russell FM. Evaluation of rotavirus, pneumococcal conjugate and human papillomavirus vaccination in four Pacific island countries: A cost-effectiveness modelling study. PLOS Medicine. 2026; 23(2), e1004604. https://doi.org/10.1371/journal.pmed.1004604
• Boujaoude MA, Devlin N, Bourke M, Dalziel K, Carvalho N. What Role Does Equity Play in Australia’s Health Technology Assessment Processes? A Review of the Pharmaceutical Benefits Advisory Committee Recommendations Regarding Vaccines. Value in Health Regional Issues. 2025; 51. https://doi.org/10.1016/j.vhri.2025.101559
• Boujaoude MA, Devlin N, Doran T, Hurley J, Cookson R, on behalf of the Exploring Distributional Equity in health (EDE) group. Strengthening Methods and International Evidence on Health Inequality Aversion. Value in Health. 2026. https://doi.org/10.1016/j.jval.2025.11.006
• Akpan E, Ku Abd Rahim KN, Devine A, Sharifa Ezat WP, Abraham P, Ali FZ, Lee SW, Tanaka T, Ghazali IM, Carvalho N. Health and economic burden of COVID-19 in Malaysia between January 2020 and December 2022. Public Health. 2026 Jan;250:105992. doi: 10.1016/j.puhe.2025.105992

2025

• Wirawan GBS, Kelly-Hanku A, Adawiyah RA, Wolter A, Hegarty B, Yuniar Y, Ridwan R, Januraga PP, Lestary H, Wulandari LPL. Public and private antenatal care access and utilisation as determinants of triple antenatal testing for HIV, syphilis, and HBV: Evidence from the Indonesian Health Survey. Women and Birth. 2026;39(1):102153. doi:10.1016/j.wombi.2025.102153.
• Peixoto HM, Bastos Gottinb LL, de Brito-Sousac JD, Sampaio V, Daumerie PG, Jambert E, Monteiroc W, Lacerdac MVG, Devine A. The cost-effectiveness of tafenoquine following screening with STANDARD™ G6PD screening for the treatment of vivax malaria in the Brazilian Public Health System. The Lancet Regional Health Americas. 2025; 51. https://doi.org/10.1016/j.lana.2025.101216
• Setiawan E, Devine A, Prameswary AD, Baird JK, Price R, Thriemer K. Malaria morbidity, mortality and associated costs in Indonesia: analysis of the National Health Insurance claim dataset. BMJ Global Health. 2025; 10. doi: 10.1136/bmjgh-2024-018255
• Rae JD, Devine A, Patekkham C, Thu AM, Delmas G, Parker DM, Maude RJ, Wiladphaingern J, Kajeechiwa L, Thwin MM, Tun SW, Simpson J & Nosten FH. The impact of mass screening and treatment interventions on malaria incidence and prevalence: a retrospective analysis of a malaria elimination programme in eastern Myanmar, and systematic review and meta-analysis. Malaria Journal. 2025.  https://doi.org/10.1186/s12936-025-05392-9
• Lim C, Maung Swea MM, Devine A, Oakleye T, Champline K, Oa PS, Sarmentoe N, Da Costa Barretof I, Givneye RC, Yane J,  Francise JR, Cooper BS. Cost-effectiveness of maintaining an active hospital microbiology laboratory service in Timor-Leste. The Lancet Regional Health Southeast Asia. 2025; 24.  https://doi.org/10.1186/s12936-025-05392-9
• Rae JD, Chen W, Diarra S, Nghiem N, Chisholm RH, Tran-Duy A, Shearer F & Devine A. Web-based models to inform health policy: A scoping review. Health Research Policy and Systems. 2025; 23. https://doi.org/10.1186/s12961-025-01367-z
• SCOPE Study Group. High daily dose Short COurse PrimaquinE after G6PD testing for the radical cure of Plasmodium vivax malaria in Indonesia and Papua New Guinea: the SCOPE implementation study protocol. BMC Infectious Diseases. 2025; 25. https://doi.org/10.1186/s12879-025-11109-9
• Le TP, Conway E, Akpan E, Abell IR, Abraham P, Baker CM, et al. (2025). Health impact and cost-effectiveness of COVID-19 booster vaccination strategies in the early post-Omicron era: a dynamic modelling study. BMJ Global Health. 10:e016096. https://doi.org/10.1136/bmjgh-2024-016096
• Atkinson SH, Suchdev PS, Bode M, …, Carvalho N, …, Pasricha SR. (2025). Getting back on track to meet global anaemia reduction targets: a Lancet Haematology Commission. Lancet Haematol. 2025 Sep;12(9):e717-e767. doi: 10.1016/S2352-3026(25)00146-2
• Bode M, Carvalho N, Leung S, Pasricha SR. (2025). Progress towards global nutrition targets and future directions. Lancet. 406(10505):808. doi: 10.1016/S0140-6736(25)01460-6.
• Blythe R, Carvalho N, Holloway-Brown J, Leung S, Oliver VL, Wang Y, Glover-Wright C, Pasricha SR, Bode M. (2025). Cost-effective targets for anaemia reduction in 191 countries: a modelling study. Lancet Haematol. 12(9):e674-e683. doi: 10.1016/S2352-3026(25)00168-1
• Oliver VL, Wang Y, Leung S, Blythe R, Glover-Wright C, Holloway-Brown J, Bode M, Pasricha SR, Carvalho N. (2025). Estimated unit costs of anaemia interventions for women of reproductive age in 193 UN member states: a costing study. Lancet Haematol. 12(9):e684-e693. doi: 10.1016/S2352-3026(25)00171-1
• Prang, KH., Rahman, A.Q., Verbunt, E. …Carvalho N,…et al. (2025). Feasibility and Acceptability of Intravenous Iron for Anaemia in Pregnancy in Bangladesh: A Demonstration Project Protocol. Glob Implement Res Appl. https://doi.org/10.1007/s43477-025-00176-4
• Abraham P, McMullin C, William T, Rajahram GS, Jelip J, ... Devine A. (2025). Household costs associated with zoonotic Plasmodium knowlesi, P. falciparum, P. vivax and P. malariae infections in Sabah, Malaysia. PLOS Neglected Tropical Diseases 19(4): e0012180. https://doi.org/10.1371/journal.pntd.0012180
• Boujaoude MA, Dalziel K, Cookson R, Devlin N, Carvalho N. (2024). Aversion to income, ethnic, and geographic related health inequality: Evidence from Australia. Social Science and Medicine. https://doi.org/10.1016/j.socscimed.2024.117495
• At Thobari J, Watts E, Carvalho N, Haposan JH, Clark A, et al. (2025). Cost effectiveness analysis of rotavirus vaccination in Indonesia. Vaccine; 43 (Part 2):126478. https://doi.org/10.1016/j.vaccine.2024.126478

2024

• Akpan E, Thean LJ, Baskota R, Mani J, Mow M, Kama M, Tuicakau M, Kado J, Romani L, Kaldor J, Engelman D, Steer A, Carvalho N. (2024). Costs of primary healthcare presentations and hospital admissions for scabies and related skin infections in Fiji, 2018–2019. PLOS Global Public Health 4(10): e0003706. https://doi.org/10.1371/journal.pgph.0003706
• Chang J, Zhu S, Zhang Y, Carvalho N, et al. (2024). Determinants of parental demand of human papillomavirus vaccination for adolescent daughters in China: contingent valuation survey. Int J Health Plann Mgmt. 1-26. doi.org/10.1002/hpm.3818
• Niyibitegeka F, Russell FM, Jit M, Carvalho N. (2024). Inequitable Distribution of Global Economic Benefits from Pneumococcal Conjugate Vaccination. Vaccines 12(7):767. doi:10.3390/vaccines12070767
• Setiawan E, Cassidy-Seyoum SA, Ley-Thriemer K, Carvalho N, Devine A. (2024). A systematic review of methods for estimating productivity losses due to illness or caregiving in low- and middle-income countries. Pharmacoeconomics 42(8):865-877. doi: 10.1007/s40273-024-01402-x
• Rwebembera J, Ngadire E, Carvalho N. et al. (2024). Intramuscular versus Enteral Penicillin Prophylaxis to Prevent Progression of Rheumatic Heart Disease: Study Protocol for a non-inferiority randomized trial (the GOALIE trial). Am Heart Journal 275: 74-85. doi.org/10.1016/j.ahj.2024.05.012
• Anwar MN, Smith L, Devine A, Mehra S, Walker CR, Ivory E, ... Hickson RI. (2024). Mathematical models of Plasmodium vivax transmission: A scoping review. PLOS COMPUTATIONAL BIOLOGY, 20(3), pp. 26-. doi:10.1371/journal.pcbi.1011931
• Wang Y, Giles ML & Carvalho N. (2024). Potential Cost-Effectiveness of Maternal Influenza Immunisation in Low-Income Countries: An Explorative Modelling Study and Value of Information Analysis to Guide Future Clinical Research. Vaccines, 12(3), doi:10.3390/vaccines12030232
• Xiong X, Carvalho N, Huang L, Chen G, Jones R, Devlin N, ... Dalziel K. (2024). Psychometric Properties of Child Health Utility 9D (CHU9D) Proxy Version Administered to Parents and Caregivers of Children Aged 2-4 Years Compared with Pediatric Quality of Life Inventory™ (PedsQL). PHARMACOECONOMICS, pp. 15-. doi:10.1007/s40273-024-01355-1
• Price DJ, Nekkab N, Monteiro WM, Villela DA, Simpson JA, Lacerda MV, ... Devin A. (2024). Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model. PLOS MEDICINE, 21(1), pp. 17-. doi:10.1371/journal.pmed.1004255

2023

• Walker C, Hickson R, Chang E, Ngor P, Sovannaroth S, Simpson J, ... Devine A. (2023). A model for malaria treatment evaluation in the presence of multiple species. EPIDEMICS, 44 pp. 9-. doi:10.1016/j.epidem.2023.100687
• Neppelenbroek NJ, de Wit GA, Dalziel K, Devlin N & Carvalho N. (2023). Use of Utility and Disability Weights in Economic Evaluation of Pediatric Vaccines. Value Health, 26(7), pp. 1098-1106. doi:10.1016/j.jval.2023.03.005
• Xiong X, Dalziel K, Huang L, Mulhern B & Carvalho N. (2023). How do common conditions impact health-related quality of life for children? Providing guidance for validating pediatric preference-based measures. Health and Quality of Life Outcomes, 21(1), pp. 11-. doi:10.1186/s12955-023-02091-4
• Tellioglu N, Chisholm RH, Campbell PT, Collinson S, Timothy J, Kollie K, Zayzay S, Devine A, McVernon J, Marks M, & Geard N. (2023). Modelling mass drug administration strategies for reducing scabies burden in Monrovia, Liberia. Epidemiology and infection, 151, e153. https://doi.org/10.1017/S0950268823001310
• Xu X, Chow EPF, Fairley CK, Chen M, Aguirre I, Goller J, Hocking J, Carvalho N, Zhang L, & Ong JJ (2023). Determinants and prediction of Chlamydia trachomatis re-testing and re-infection within 1 year among heterosexuals with chlamydia attending a sexual health clinic. Frontiers in public health, 10, 1031372. https://doi.org/10.3389/fpubh.2022.1031372
• Fernando-Canavan L, Abraham P, Devlin N, Duy-Tran A. (2023) Health-related quality of life in patients with extremity bone sarcoma after surgical treatment: a systematic review. Qual Life Res. doi:10.1007/s11136-023-03554-3
• Alexander M, Collins I, Abraham P, Underhill C, Harris S, Torres J, Sharma S, Solomon B, Tran-Duy A, & Burbury K. (2023). Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial. Internal medicine journal, 53(12), 2346–2349. doi:10.1111/imj.16292

2022

• Goller JL, Coombe J, Temple-Smith M, Bittleston H, Sanci L, Guy R, Fairley C, Regan D, Carvalho N, ... Hocking J S. (2022). Management of Chlamydia Cases in Australia (MoCCA): protocol for a non-randomised implementation and feasibility trial. BMJ OPEN, 12(12), pp. 9-. doi:10.1136/bmjopen-2022-067488
• Akpan E, Hossain SJ, Devine A, Braat S, Hasan MI, Tipu SMMU, Bhuiyan MSA, Hamadani JD, Biggs BA, Pasricha SR & Carvalho N. (2022). Cost-effectiveness of universal iron supplementation and iron-containing micronutrient powders for anemia among young children in rural Bangladesh: analysis of a randomized, placebo-controlled trial. The American journal of clinical nutrition, 116(5), 1303–1313. doi:10.1093/ajcn/nqac225
• Carvalho N, Sousa TV, Mizdrak A, Jones A, Wilson N, & Blakely T.(2022). Comparing health gains, costs and cost-effectiveness of 100s of interventions in Australia and New Zealand: an online interactive league table. Population health metrics, 20(1), 17. doi:10.1186/s12963-022-00294-3
• Marthias, T., McPake, B., Carvalho, N., Millett, C., Anindya, K., Saputri, N. S., ... Lee, J. T. (2022). Associations between Indonesia's national health insurance, effective coverage in maternal health and neonatal mortality: a multilevel interrupted time-series analysis 2000-2017. Journal of Epidemiology and Community Health, 76(12), pp. 999-1010. doi:10.1136/jech-2021-217213
• Thean, L. J., Romani, L., Engelman, D., Wand, H., Jenney, A., Mani, J., Paka, J., Cua, T., Taole, S., Silai, M., Ashwini, K., Sahukhan, A., Kama, M., Tuicakau, M., Kado, J., Parnaby, M., Carvalho, N., Whitfeld, M., Kaldor, J., & Steer, A. C. (2022). Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020. The Lancet regional health. Western Pacific, 22, 100433 doi:10.1016/j.lanwpc.2022.100433
• Mow, M., Thean, L. J., Parnaby, M., Mani, J., Rafai, E., Sahukhan, A., ... Carvalho, N. (2022). Costs of mass drug administration for scabies in Fiji. Plos Neglected Tropical Diseases, 16(2), pp. 13-. doi:10.1371/journal.pntd.0010147
• At Thobari, J., Sutarman, Mulyadi, A. W., Watts, E., Carvalho, N., Debellut, F., ... Bines, J. E. (2022). Direct and indirect costs of acute diarrhea in children under five years of age in Indonesia: Health facilities and community survey. Lancet Regional Health-Western Pacific, 19 pp. 13-. doi:10.1016/j.lanwpc.2021.100333
• Lake, S. J., Engelman, D., Sokana, O., Nasi, T., Boara, D., Marks, M., ... Carvalho, N. (2022). Health-related quality of life impact of scabies in the Solomon Islands. Transactions of the Royal Society of Tropical Medicine and Hygiene, 116(2), pp. 148-156. doi:10.1093/trstmh/trab096
• Ferdinand, A., Nightingale, C., Carvalho, N., Hocking, J., Ludwick, T., Creagh, N., ... McEwan, C. (2022). Evaluation of COVID-19 rapid antigen testing at a Victorian large-scale construction project.
• Dale, K. D., Abayawardana, M. J., McBryde, E. S., Trauer, J. M. & Carvalho, N. (2022). Modeling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low-Incidence Setting. American Journal of Epidemiology, 191(2), pp. 255-270. doi:10.1093/aje/kwab150
• Xiong, X., Dalziel, K., Carvalho, N., Xu, R. & Huang, L. (2022). Association between 24-hour movement behaviors and health-related quality of life in children. Quality of Life Research, 31(1), pp. 231-240. doi:10.1007/s11136-021-02901-6
• Rae, J. D., Nosten, S., Kajeechiwa, L., Wiladphaingern, J., Parker, D. M., Landier, J., Thu, A. M., Dah, H., Be, A., Cho, W. C., Paw, K., Paw, E. S., Shee, P. B., Poe, C., Nu, C., Nyaw, B., Simpson, J. A., Devine, A., Maude, R. J., Moo, K. L., … Nosten, F. H. (2022). Surveillance to achieve malaria elimination in eastern Myanmar: a 7-year observational study. Malaria journal, 21(1), 175 doi:10.1186/s12936-022-04175-w
• Brito-Sousa, J. D., Peixoto, H. M., Devine, A., Silva-Neto, A. V., Balieiro, P. C., Sampaio, V. S., ... Monteiro, W. M. (2022). Real-life quantitative G6PD screening in Plasmodium vivax patients in the Brazilian Amazon: A cost-effectiveness analysis. Plos Neglected Tropical Diseases, 16(3), pp. 12-. doi:10.1371/journal.pntd.0010325
• Devine, A., Xiong, X., Gottlieb, S. L., de Mello, M. B., Fairley, C. K. & Ong, J. J. (2022). Health-related quality of life in individuals with genital herpes: a systematic review. Health and Quality of Life Outcomes, 20(1), pp. 16-. doi:10.1186/s12955-022-01934-w
• Lim, M., Devine, A., Gray, R. T., Kwon, J. A., Hutchinson, J. L. & Ong, J. J. (2022). Lifetime cost of HIV management in Australia: an economic model†. Sexual Health, 19(6), pp. 517-524. doi:10.1071/SH21250
• Abraham, P., Manski-Nankervis, J. A., Biezen, R., Hallinan, C. M., Gibney, K. B., Sanci, L., & Ride, J. (2022). Costing of an Australian general practice COVID-19 drive-through testing and respiratory clinic. BMC primary care, 23(1), 58. doi:10.1186/s12875-022-01664-4

2021

• Carvalho, N., Abraham, P., Devine, A., Akpan, E. & McPake, B. (2021). The economic burden of COVID-19 on healthcare services in Malaysia.
• Blakely, T., Thompson, J., Bablani, L., Andersen, P., Ouakrim, D. A., Carvalho, N., ... Stevenson, M. (2021). Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia. JAMA Health Forum, 2(7), pp. 13-. doi:10.1001/jamahealthforum.2021.1749
• Thean, L. J., Romani, L., Engelman, D., Wand, H., Jenney, A., Mani, J., ... Steer, A. C. (2022). Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020. Lancet Regional Health-Western Pacific, 22 pp. 9-. doi:10.1016/j.lanwpc.2022.100433
• Anindya, K., Marthias, T., Vellakkal, S., Carvalho, N., Atun, R., Morgan, A., ... Lee, J. T. (2021). Socioeconomic inequalities in effective service coverage for reproductive, maternal, newborn, and child health: a comparative analysis of 39 low-income and middle-income countries. Eclinicalmedicine , 40 pp. 10-. doi:10.1016/j.eclinm.2021.101103
• Xiong, X., Huang, L., Carvalho, N. & Dalziel, K. (2021). Physical activity is critical for children’s quality of life.
• Vu, M., Carvalho, N., Clarke, P. M., Buchbinder, R. & An, T. (2021). Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis. Journal of Rheumatology, 48(8), pp. 1221-1229. doi:10.3899/jrheum.200231
• Blakely, A., Thompson, J., Bablani, L., Andersen, P., Ait Ouakrim, D., Carvalho, N., ... STEVENSON, M. (2021). We need to talk about elimination vs suppression in Australia again.
• Abraham, P., Bablani, L., Carvalho, N. & Blakely, A. (2021). Yes, lockdowns are costly. But the alternatives are worse.
• Thompson, J., Carvalho, N. & Blakely, T. (2021). The probability of the 6-week lockdown in Victoria (commencing 9 July 2020) achieving elimination of community transmission of SARS-CoV-2. Medical Journal of Australia, 215(2), pp. 96-+. doi:10.5694/mja2.51157
• Thean, L. J., Romani, L., Engelman, D., Jenney, A., Wand, H., Mani, J., ... Steer, A. C. (2021). Prospective Surveillance of Primary Healthcare Presentations for Scabies and Bacterial Skin Infections in Fiji, 2018-2019. American Journal of Tropical Medicine and Hygiene, 105(1), pp. 230-237. doi:10.4269/ajtmh.20-1459
• Rae, J. D., Landier, J., Simpson, J. A., Proux, S., Devine, A., Maude, R. J., ... Nosten, F. H. (2021). Longitudinal trends in malaria testing rates in the face of elimination in eastern Myanmar: a 7-year observational study. BMC Public Health, 21(1), pp. 12-. doi:10.1186/s12889-021-11749-x
• Agius, P., Simpson, J., Dini, S., Gething, P., Devine, A. & Fowkes, F. (2021). Applying novel multi-disciplinary methodologies to accelerate malaria elimination. International Journal of Epidemiology, 50 pp. 8-8. doi:10.1093/ije/dyab168.014
• Devine, A., Battle, K. E., Meagher, N., Howes, R. E., Dini, S., Gething, P. W., ... Lubell, Y. (2021). Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study. PLOS Medicine, 18(6), pp. 20-. doi:10.1371/journal.pmed.1003614
• Devine, A., Vahanian, A., Sawadogo, B., Zan, S., Bocoum, F. Y., Kelly, H., ... Mayaud, P. (2021). Costs and cost-effectiveness of cervical cancer screening strategies in women living with HIV in Burkina Faso: The HPV in Africa Research Partnership (HARP) study. PLOS One, 16(3), pp. 16-. doi:10.1371/journal.pone.0248832
• Bierhoff, M., Angkurawaranon, C., Rijken, M. J., Sriprawa, K., Kobphan, P., Nosten, F. N., ... Devine, A. (2021). Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis. BMC Pregnancy and Childbirth, 21(1), pp. 12-. doi:10.1186/s12884-021-03612-z
• Lim, M., Devine, A., Gray, R., Kwon, J., Hutchinson, J. & Ong, J. (2021). LIFETIME COST OF HIV MANAGEMENT IN AUSTRALIA: A MODELLING STUDY. Sexual Health, 18(4), pp. VIII-VIII.

2020

• Devine, A., Howes, R.E., Price, D.J., Moore, K.A., Ley, B., Simpson, J.A., Dittrich, S., Price, R.N. 2020. Cost-effectiveness analysis of sex-stratified Plasmodium vivax treatment strategies using available G6PD diagnostics to accelerate access to radical cure. American Journal of Tropical Medicine and Hygiene, 103(1), pp.394-403. doi:10.4269/ajtmh.19-0943
• Carvalho, N., Hoque, M. E., Oliver, V. L., Byrne, A., Kermode, M., Lambert, P., ... Morgan, A. (2020). Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings. BMC Medicine, 18(1), pp. 18-. doi:10.1186/s12916-020-01658-y
• Bablani, L., Thompson, J., Andersen, P., Katar, A., Abraham, P., Boujaoude, M., ... Blakely, A. (2020). Determining optimal COVID-19 policy responses for Pakistan and Khyber Pakhtunkhwa.
• Bablani, L., Thompson, J., Andersen, P., Katar, A., Abraham, P., Boujaoude, M., ... Blakely, A. (2020). Determining optimal COVID-19 policy responses for Armenia.
• Thean, L. J., Jenney, A., Engelman, D., Romani, L., Wand, H., Mudaliar, J., ... Steer, A. C. (2020). Hospital admissions for skin and soft tissue infections in a population with endemic scabies: A prospective study in Fiji, 2018-2019. PLOS Neglected Tropical Diseases, 14(12), pp. 14-. doi:10.1371/journal.pntd.0008887

2019 and earlier

• Devine, A., Pasaribu, A., Teferi, T., Huong-Thu, P., Contantia, F., Thuy-Nhien, N., ... Lubell, Y. (2018). ECONOMIC COSTS OF PLASMODIUM VIVAX EPISODES: A MULTI-COUNTRY COMPARATIVE ANALYSIS USING PRIMARY TRIAL DATA. American Journal of Tropical Medicine and Hygiene, LA, New Orleans, 99(4), pp. 427-427.
• Carvalho, N., Petrie, D., Chen, L., Salomon, J. A. & Clarke, P. (2019). The impact of Medicare part D on income-related inequality in pharmaceutical expenditure. International Journal for Equity in Health, 18 pp. 11-. doi:10.1186/s12939-019-0955-9
• Devine, A., Pasaribu, A., Teferi, T., Huong-Thu, P., Contantia, F., Thuy-Nhien, N., ... Lubell, Y. (2018). ECONOMIC COSTS OF PLASMODIUM VIVAX EPISODES: A MULTI-COUNTRY COMPARATIVE ANALYSIS USING PRIMARY TRIAL DATA. American Journal of Tropical Medicine and Hygiene, LA, New Orleans, 99(4), pp. 427-427.
• Carvalho, N., Jit, M., Cox, S., Yoong, J. & Hutubessy, R. C. (2018). Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework. Pharmacoeconomics, 36(1), pp. 79-90. doi:10.1007/s40273-017-0569-2
• Boujaoude, M., Mirelman, A. J., Dalziel, K. & Carvalho, N. (2018). Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countries. Cost-Effectiveness and Resource Allocation, 16 pp. 14-. doi:10.1186/s12962-018-0102-2
• Hua, X., Carvalho, N., Tew, M., Huang, E. S., Herman, W. H. & Clarke, P. (2016). Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013. JAMA-Journal of the American Medical Association, 315(13), pp. 1400-1402. doi:10.1001/jama.2016.0126
• Allen, K. J., Panjari, M., Koplin, J. J., Ponsonby, A., Vuillermin, P., Gurrin, L. C., ... Dharmage, S. C. (2015). VITALITY trial: protocol for a randomised controlled trial to establish the role of postnatal vitamin D supplementation in infant immune health. BMJ Open, 5(12), pp. 8-. doi:10.1136/bmjopen-2015-009377

2026

• Bailey, C., Van Dam, N., Davies, J. N., Schilling, C., & Galante, J. (2026). Quality of life, healthcare use and cost of practice from a nationally representative Australian survey to inform future economic evaluations of contemplative practices. Mindfulness. https://doi.org/10.1007/s12671-026-02788-9
• Das, N., Nguyen, D., Lee, P., Robinson, S., & Gao, L. (2026). Estimating the health and economic burden of stroke among informal caregivers in Australia using Productivity Adjusted Life Year (PALY). European Journal of Cardiovascular Nursing, zvag004. https://doi.org/10.1093/eurjcn/zvag004
• Elkin, J., Schilling, C., Hii, M. W., Choong, P. F., Dowsey, M., & Shadbolt, C. (2026). Diagnostic performance of a new framework for identifying obesity. Journal of Internal Medicine, 299(1), 172–175. https://doi.org/10.1111/joim.70049
• Lee, P., Bivard, A., Kurunawai, C., Willcourt, M., Tan, A., Mahadevan, J., Waters, M., Harvey, J., Van Eunen, J., Dixon, K., Piantedosi, B., Davis, S., Donnan, G., Jannes, J., Kleinig, T., & Gao, L. (2026). Quantifying the cost savings of the South Australian Telestroke Service. Journal of Telemedicine and Telecare, 1357633X251389689. https://doi.org/10.1177/1357633X251389689
• Leslie, K., Braat, S., Darvall, J. N., Peyton, P. J., Devlin, N., Myles, P. S., Corcoran, T. B., Short, T. G., Chan, M. T. V., Olesnicky, B. L., Tran-Duy, A., Maxwell-Wright, H., Schultz-Ferguson, C., Sidiropoulos, S., & Story, D. A. (2026). Sugammadex, neostigmine, and postoperative pulmonary complications: protocol of the SNaPP multicentre randomised controlled trial. BJA Open, 17. https://doi.org/10.1016/j.bjao.2026.100531
• Mordaunt, D. A., Stark, Z., Elshaug, A. G., & Schilling, C. (2026). Genomic testing in Australia: A budget impact analysis using diffusion modeling from a healthcare system perspective. Value in Health, 29(3), 375–382. https://doi.org/10.1016/j.jval.2025.09.3067
• Schilling, C., Wawryk, O., Collins, A., Sundararajan, V., Le, B. H., & Philip, J. (2026). Early palliative care and quality of end-of-life care for people with terminal cancer, Victoria, 2018–2023: A retrospective, population-based cohort study. Medical Journal of Australia, 224(1), e70128. https://doi.org/10.5694/mja2.70128
• Toan, A. T. N., Phung, T. L., Tran-Duy, A., & Minh, H. V. (2026). Cost-effectiveness of add-on ivabradine versus standard pharmacotherapy in the treatment of heart failure in Vietnam: An analysis from a health system perspective. Value in Health Regional Issues, 101594. https://doi.org/10.1016/j.vhri.2026.101594
• Tran-Duy, A., Asbury, S., Spelman, T., Paterson, D. L., Buising, K. L., McDougall, C., Solomon, M., Crawford, R., Adie, S., Molnar, R., Mulford, J., Harris-Brown, T., Roney, J., de Steiger, R., Peel, T. N., & ASAP Trial Group. (2026). Economic evaluation of the addition of vancomycin to cefazolin prophylaxis in patients undergoing arthroplasty. PharmacoEconomics. https://doi.org/10.1007/s40273-026-01609-0
• Tran-Duy, A., Zhao, T., Fernando-Canavan, L., Clarke, P., Ekinci, E., O'Neal, D., & Devlin, N. (2026). Health utilities and disutilities associated with complications of type 1 diabetes: A systematic review and recommendations for health economic models. Value in Health. https://doi.org/10.1016/j.jval.2026.01.011

2025

• Bailey, C., Dalziel, K., Constable, L., Devlin, N. J., Hiscock, H., Skouteris, H., & Peasgood, T. (2025). The performance of the EQ-HWB-S as a measure of quality-of-life of caregivers in families that have experienced adverse events. The European Journal of Health Economics, 26(1), 7–21. https://doi.org/10.1007/s10198-024-01688-w
• Bailey, C., Dalziel, K., Constable, L., & Peasgood, T. (2025). Validity and reliability of the EQ-HWB in parents of children with health conditions. Value in Health, 28(9), 1370–1379. https://doi.org/10.1016/j.jval.2025.05.013
• Bailey, C., & Peasgood, T. (2025). Content validity of the EQ-HWB in caregivers of children with health conditions. The Patient - Patient-Centered Outcomes Research, 18(6), 661–671. https://doi.org/10.1007/s40271-025-00749-3
• Bailey, C., Peasgood, T., Michalowsky, B., & Engel, L. (2025). The psychometric performance of the EQ health and wellbeing in caregivers of persons living with dementia. Value in Health, 28(8), 1221–1230. https://doi.org/10.1016/j.jval.2025.04.2168
• Bailey, C., Trapani, K., Davies, J. N., Van Dam, N., Galante, J., & Peasgood, T. (2025). The psychometric performance of the EQ-HWB-9 for measuring health and wellbeing in a general population sample from Australia and New Zealand. Quality of Life Research, 34(12), 3707–3719. https://doi.org/10.1007/s11136-025-04061-3
• Chima, S., Martinez-Gutierrez, J., Hunter, B., Laughlin, A., Chondros, P., Lumsden, N., Boyle, D., Nelson, C., Amores, P., Tran-Duy, A., Manski-Nankervis, J. A., & Emery, J. (2025). Future Health Today and patients at risk of undiagnosed cancer: a pragmatic cluster randomised trial of quality-improvement activities in general practice. British Journal of General Practice, 75(754), e306–e315. https://doi.org/10.3399/BJGP.2024.0491
• Dakin, H. A., Gao, N., Leal, J., Holman, R. R., Tran-Duy, A., & Clarke, P. (2025). Using QALYs as an outcome for assessing global prediction accuracy in diabetes simulation models. Medical Decision Making, 45(1), 45–59. https://doi.org/10.1177/0272989X241285866
• Darvall, J. N., De Silva, A. P., Von Ungern-Sternberg, B., Story, D. A., Davidson, A. J., Allen, M. L., Tran-Duy, A., Schultz-Ferguson, C., Ha, V., Braat, S., & Leslie, K. (2025). Chewing gum to treat postoperative nausea and vomiting in female patients: A multicenter randomized trial. Anesthesiology, 142(3), 454–464. https://doi.org/10.1097/ALN.0000000000005283
• Darvall, J. N., De Silva, A. P., Von Ungern-Sternberg, B. S., Story, D. A., Davidson, A. J., Allen, M. L., Tran-Duy, A., Schultz-Ferguson, C., Ha, V., Braat, S., & Leslie, K. (2025). Chewing gum and postoperative nausea and vomiting: Reply. Anesthesiology, 143(3), 787–788. https://doi.org/10.1097/ALN.0000000000005597
• Davies, J. N., Bailey, C., Galante, J., & Van Dam, N. T. (2025). Prevalence and predictors of meditation use in Australia and New Zealand: Results from a nationally representative survey. BMC Complementary Medicine and Therapies, 26(1), 11. https://doi.org/10.1186/s12906-025-05183-4
• Duong, V., Tirant, K., Raza Khan, U., Marsden, P., Steinfort, D., Wilsmore, N., Faisal, W., Suleiman, M., Tran-Duy, A., Amores, P., Hannan, L. M., & Muruganandan, S. (2025). Evaluation of a digital health model of care for the management of adults with symptomatic malignant pleural effusion. Respirology Case Reports, 13(6). https://doi.org/10.1002/rcr2.70194
• Ekegren, C. L., Lee, P., Gabbe, B. J., Hill, K. D., Keeves, J., Kimmel, L., Kunstler, B., Reeder, S. C., & Brusco, N. K. (2025). Uptake of telehealth services by people recovering from road trauma in Victoria, Australia. Trauma, 27(2), 149–156. https://doi.org/10.1177/14604086241272544
• Holmes-Truscott, E., Jordan, J., Churilov, L., Davis, W., Glastras, S., Klaic, M., Read, M., Tran-Duy, A., O'Neal, D., & Ekinci, E. (2025). Accelerating diabetes innovation for real-world community impact through interdisciplinary research: Who is at the table? Diabetic Medicine, 42(7), 1–5. https://doi.org/10.1111/dme.70057
• Lee, P., Wu, T., Chen, C., Lin, L., Garcia-Esperon, C., Cordato, D. J., Miteff, F., Kleinig, T. J., Choi, P. M. C., Xin, C., Barber, P. A., Ranta, A., Fink, J. N., Parsons, M. W., Gao, L., & International Study Group. (2025). Cost-effectiveness of endovascular thrombectomy in large vessel occlusion stroke for the very elderly. Neurology, 105(9), e214079. https://doi.org/10.1212/WNL.0000000000214079
• Rele, S., Schilling, C., Shadbolt, C., Spelman, T., Taylor, N. F., Dowsey, M. M., & Choong, P. F. M. (2025). Clinical and cost-effectiveness of earlier discharge from acute hospital after total joint arthroplasty. ANZ Journal of Surgery, 95(1–2), 180–188. https://doi.org/10.1111/ans.19322
• Rele, S., Shadbolt, C., Schilling, C., Thuraisingam, S., Trieu, J., Choong, E. L. P., Gould, D., Taylor, N. F., Dowsey, M. M., & Choong, P. F. M. (2025). Validation of the Clavien-Dindo classification and Comprehensive Complication Index as measures of morbidity following total hip and knee arthroplasty. The Bone & Joint Journal, 107-B(1), 81–88. https://doi.org/10.1302/0301-620X.107B1.BJJ-2023-1400.R2
• Sarker, A. R., Islam, R., & Tran-Duy, A. (2025). Out-of-pocket cost and financial catastrophe of patients with cancer: The alarming cost-of-illness in Bangladesh. International Journal for Equity in Health, 24(1), 1–13. https://doi.org/10.1186/s12939-025-02421-6
• Schilling, C., Bailey, C., Merollini, K., Giles, A., Platts, C., Currow, D. C., Button, E., Runacres, F., Crawford, G. B., Merlo, G., Yoong, J., Philip, J., Tieman, J., Agar, M. R., Yates, P., Hudson, P., Sundararajan, V., Carter, H., & McCaffrey, N. (2025). Toward a comprehensive research agenda: Exploring the health economics of palliative care in Australia. BMC Palliative Care, 24(1), 276. https://doi.org/10.1186/s12904-025-01867-3
• West, K. L., Spelman, T., Cui, W., Latham, S., Deij, S., Minck, S., Mason, S., Saunders, C., Poliness, C., James, P. A., Wheeler, G., Keogh, L. A., Best, S., & Phillips, K. A. (2025). Evaluation of a telehealth service to support breast cancer prevention medication uptake: A protocol of a mixed methods study. BMJ Open, 15(6), e098198. https://doi.org/10.1136/bmjopen-2024-098198
• Zaloumis, S., Summers, M. J., Presneill, J. J., Bellomo, R., Chapple, L. A. S., Chapman, M. J., Deane, A. M., Ferrie, S., French, C., Hurford, S., Kakho, N., Maiden, M. J., O'Connor, S. N., Peake, S. L., Ridley, E. J., Tran-Duy, A., Williams, P. J., Young, P. J., & Karahalios, A. (2025). TARGET Protein: The effect of augmented administration of enteral protein to critically ill adults on clinical outcomes—statistical analysis plan for a cluster randomized, cross-sectional, double cross-over clinical trial. Trials, 26(1). https://doi.org/10.1186/s13063-025-08759-0

2024

• Zhou, Y., Patten, L., Spelman, T., Bunzli, S., Choong, P. Dowsey, M. & Schilling, C. (2024). Predictive Tool Use and Willingness for Surgery in Patients With Knee Osteoarthritis. JAMA NETWORK OPEN, 7(3),e240890. https://doi:10.1001/jamanetworkopen.2024.0890
• Panganiban, H.P., Nguyen, C.D., Adelhamid, Y.A., Ankravs, M., Karahalios, E., MacIsaac, C., Rechnitzer, T., Sharrock, L., Tran-Duy, A., Fazio, T. & Deane, A.M. (2024). Feasibility of Embedding a Randomised Clinical Trial (RCT) into an Electronic Medical Record (EMR) for Patients Admitted to an Intensive Care Unit (ICU). STUDIES IN HEALTH TECHNOLOGY AND INFORMATICS, 310. pp. 1420-1421. https://doi.org/10.3233/shti231224
• Nguyen, C. D., Panganiban, H.P., Fazio, T., Karahalios A., Akravs., MacIsaac C.M., Rechnitzer, T., Arno, L., Tran-Duy, A., McAlister S., Abdelhamid Y.A. & Deane, A.M. (2024). A Randomized Noninferiority Trial to Compare Enteral to Parenteral Phosphate Replacement on Biochemistry, Waste, and Environmental Impact and Healthcare Cost in Critically Ill Patients With Mild to Moderate Hypophosphatemia. Crit Care Med. https://doi.org/10.1097/CCM.0000000000006255

2023

• Fernando-Canavan, L., Abraham, P., Devlin, N. & Tran-Duy, A. (2023). Health-related quality of life in patients with extremity bone sarcoma after surgical treatment: a systematic review. QUALITY OF LIFE RESEARCH, pp. 18-. doi:10.1007/s11136-023-03554-3
• Peel, T. N., Astbury, S., Cheng, A. C., Paterson, D. L., Buising, K. L., Spelman, T., Tran-Duy, A., Adie, S., Boyce, G., McDougall, C., Molnar, R., Mulford, J., Rehfisch, P., Solomon, M., Crawford, R., Harris-Brown, T., Roney, J., Wisniewski, J., de Steiger, R. & ASAP Trial Group, (2023). Trial of Vancomycin and Cefazolin as Surgical Prophylaxis in Arthroplasty. New England Journal of Medicine, 389 (16), pp.1488-1498. https://doi.org/10.1056/NEJMoa2301401
• Gorniak, M., Pardillo, M., Keating, C., Brown, C., & Schilling, C. (2023). Net cost savings arising from patient completion of an active self-management program. PloS one, 18(11), e0293352. https://doi.org/10.1371/journal.pone.0293352
• Schilling, C., Tew, M., Bunzli, S., Shadbolt, C., Lohmander, L. S., Balogh, Z. J., Paolucci, F., Choong, P. F., Dowsey, M. M., & Clarke, P. (2023). An Economic Model for Estimating Trial Costs with an Application to Placebo Surgery Trials. Applied health economics and health policy, 21(2), 263–273. https://doi.org/10.1007/s40258-022-00775-4
• Zhou, Y., Dowsey, M., Spelman, T., Choong, P., & Schilling, C. (2023). SMART choice (knee) tool: a patient-focused predictive model to predict improvement in health-related quality of life after total knee arthroplasty. ANZ journal of surgery, 93(1-2), 316–327. https://doi.org/10.1111/ans.18250
• Khorshidi, H. A., Aickelin, U. & de Silva, A. (2023). Evaluation of the Early Intervention Physiotherapist Framework for Injured Workers in Victoria, Australia: Data Analysis Follow-Up. HEALTHCARE, 11(15), pp. 11-. doi:10.3390/healthcare11152205
• Adhikari, D., Jiang, W., Zhan, J., He, Z., Rawat, D. B., Aickelin, U. & Khorshidi, H. A. (2023). A Comprehensive Survey on Imputation of Missing Data in Internet of Things. ACM COMPUTING SURVEYS, 55(7), pp. 38-. doi:10.1145/3533381

2022

• Clarke, P.M., Tran-Duy, A., Roope, L.S.J. et al. The comparative mortality of an elite group in the long run of history: an observational analysis of politicians from 11 countries. Eur J Epidemiol 37, 891–899 (2022). https://doi.org/10.1007/s10654-022-00885-2
• Zhou, Y., Gould, D., Choong, P., Dowsey, M., & Schilling, C. (2022). Implementing predictive tools in surgery: A narrative review in the context of orthopaedic surgery. ANZ journal of surgery, 92(12), 3162–3169. https://doi.org/10.1111/ans.18044
• La, D.T.V., Zhao, Y., Arokiasamy, P., Atun, R., Mercer, S., Marthias, T., McPake, B., Pati, S., Palladino, R, Lee, J.T. (2022). Multimorbidity and out-of-pocket expenditure for medicines in China and India. BMJ GLOBAL HEALTH, 7(11). https://doi.org/10.1136/bmjgh-2021-007724
• Zhou, Y., Weeden, C., Patten, L., Dowsey, M., Bunzli, S., Choong, P., & Schilling, C. (2022). Evaluating willingness for surgery using the SMART Choice (Knee) patient prognostic tool for total knee arthroplasty: study protocol for a pragmatic randomised controlled trial. BMC musculoskeletal disorders, 23(1), 179. https://doi.org/10.1186/s12891-022-05123-0
• Farhadinia, B., Aickelin, U., & Khorshidi, H. A. (2022). A parametric similarity measure for extended picture fuzzy sets and its application in pattern recognition. Iranian Journal of Fuzzy Systems, 19(6), 141-160. doi: 10.22111/ijfs.2022.7217
• Aramesh, S., Aickelin, U. & Akbarzadeh Khorshidi, H. A hybrid projection method for resource-constrained project scheduling problem under uncertainty. Neural Comput & Applic 34, 14557–14576 (2022). https://doi.org/10.1007/s00521-022-07321-2
• Hafezalkotob, A., Fardi, K., Aickelin, U., Chaharbaghi, S. & Akbarzadeh Khorshidi, H. (2022). A cooperative robust human resource allocation problem for healthcare systems for disaster management. Computers and Industrial Engineering, 170, https://doi.org/10.1016/j.cie.2022.108283
• Bailey, C., Howell, M., Raghunandan, R., Salisbury, A., Chen, G., Coast, J., Craig, J. C., Devlin, N. J., Huynh, E., Lancsar, E., Mulhern, B. J., Norman, R., Petrou, S., Ratcliffe, J., Street, D. J., Howard, K., Viney, R., & Quality of Life in Kids: Key Evidence to Strengthen Decisions in Australia (QUOKKA), Tools for Outcomes Research to Measure, Value Child Health (TORCH) Project Teams (2022). Preference Elicitation Techniques Used in Valuing Children's Health-Related Quality-of-Life: A Systematic Review. PharmacoEconomics, 40(7), 663–698. https://doi.org/10.1007/s40273-022-01149-3
• Shannon Newman, June McLoughlin, Helen Skouteris, Claire Blewitt, Edward Melhuish & Cate Bailey (2022) Does an integrated, wrap-around school and community service model in an early learning setting improve academic outcomes for children from low socioeconomic backgrounds?, Early Child Development and Care, 192:5, 816-830, DOI: 10.1080/03004430.2020.1803298
• Bailey, C., Skouteris, H., Harrison, C. L., Hill, B., Thangaratinam, S., Teede, H., & Ademi, Z. (2022). A Comparison of the Cost-Effectiveness of Lifestyle Interventions in Pregnancy. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research, 25(2), 194–202. https://doi.org/10.1016/j.jval.2021.07.013

2021

• Tran-Duy, A., Knight, J., Clarke, P.M. et al. Development of a life expectancy table for individuals with type 1 diabetes. Diabetologia 64, 2228–2236 (2021). https://doi.org/10.1007/s00125-021-05503-6
• Tran-Duy, A., Morrisroe, K., Clarke, P., Stevens, W., Proudman, S., Sahhar, J., Nikpour, M., & Australian Scleroderma Interest Group (ASIG) (2021). Cost-Effectiveness of Combination Therapy for Patients With Systemic Sclerosis-Related Pulmonary Arterial Hypertension. Journal of the American Heart Association, 10(7), e015816. https://doi.org/10.1161/JAHA.119.015816
• Deij, S., Madsen, J. B. & Puzzello, L. (2021). When are instruments generated from geographic characteristics in bilateral relationships invalid? JOURNAL OF APPLIED ECONOMETRICS, 36(4), pp. 437-452. doi:10.1002/jae.2815
• Hadi Akbarzadeh Khorshidi & Uwe Aickelin (2021) Multicriteria group decision-making under uncertainty using interval data and cloud models, Journal of the Operational Research Society, 72:11, 2542-2556, DOI: 10.1080/01605682.2020.1796541
• Khorshidi, H. A. & Aickelin, U. (2021). Constructing classifiers for imbalanced data using diversity optimisation. INFORMATION SCIENCES, 565 pp. 1-16. doi:10.1016/j.ins.2021.02.069
• Farhadinia, B., Aickelin, U. & Khorshidi, H. (2021). Higher order hesitant fuzzy choquet integral operator and its application to multiple criteria decision making. Iranian Journal of Fuzzy Systems, 18(1), pp. 1-16. doi:10.22111/ijfs.2021.5868
• Bailey, C., Skouteris, H., Morris, H., O'Donnell, R., Hill, B., & Ademi, Z. (2021). Economic evaluation methods used in home-visiting interventions: A systematic search and review. Health & social care in the community, 29(6), 1650–1667. https://doi.org/10.1111/hsc.13349

2020 and earlier

• Fernando-Canavan L., Gust A., Hsueh A., Tran-Duy A., Kirk M., Brooks P., Knight J. (2021) Measuring the economic impact of hospital-acquired complications on an acute health service. Australian Health Review 45, 135-142.
• Vu, M., Carvalho, N., Clarke, P. M., Buchbinder, R., & Tran-Duy, A. (2021). Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis. The Journal of rheumatology, 48(8), 1221–1229. https://doi.org/10.3899/jrheum.200231
• Tran-Duy, A., Knight, J., Palmer, A. J., Petrie, D., Lung, T. W. C., Herman, W. H., Eliasson, B., Svensson, A. M., & Clarke, P. M. (2020). A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes. Diabetes care, 43(8), 1741–1749. https://doi.org/10.2337/dc19-2249
• Akbarzadeh Khorshidi, H., Hassani-Mahmooei, B., & Haffari, G. (2020). An Interpretable Algorithm on Post-injury Health Service Utilization Patterns to Predict Injury Outcomes. Journal of occupational rehabilitation, 30(3), 331–342. https://doi.org/10.1007/s10926-019-09863-0
• Nikfalazar, S., Yeh, CH., Bedingfield, S., & Akbarzadeh Khorshidi, H. Missing data imputation using decision trees and fuzzy clustering with iterative learning. Knowl Inf Syst 62, 2419–2437 (2020). https://doi.org/10.1007/s10115-019-01427-1
• Bailey, C., Skouteris, H., Harrison, C. L., Boyle, J., Bartlett, R., Hill, B., Thangaratinam, S., Teede, H., & Ademi, Z. (2020). Cost Effectiveness of Antenatal Lifestyle Interventions for Preventing Gestational Diabetes and Hypertensive Disease in Pregnancy. PharmacoEconomics - open, 4(3), 499–510. https://doi.org/10.1007/s41669-020-00197-9
• Bailey, C., Tawia, S., & McGuire, E. (2020). Breastfeeding Duration and Infant Sleep Location in a Cohort of Volunteer Breastfeeding Counselors. Journal of human lactation : official journal of International Lactation Consultant Association, 36(2), 354–364. https://doi.org/10.1177/0890334419851801

2026

• Schilling, C., Wawryk, O., Collins, A., Sundararajan, V., Le, B. H., & Philip, J. (2026). Early palliative care and quality of end-of-life care for people with terminal cancer, Victoria, 2018–2023: A retrospective, population-based cohort study. Medical Journal of Australia, 224(1), e70128. https://doi.org/10.5694/mja2.70128


• Sjaaf, F., & Schilling, C. (2025). A rapid review of the effectiveness and cost-effectiveness of palliative care, with a focus on generalisability for Australia (Working Paper No. 02/25). ISSN 2982-0510. https://doi.org/10.26188/29252276

2025

• Schilling, C., Bailey, C., Merollini, K., Giles, A., Platts, C., Currow, D. C., Button, E., Runacres, F., Crawford, G. B., Merlo, G., Yoong, J., Philip, J., Tieman, J., Agar, M. R., Yates, P., Hudson, P., Sundararajan, V., Carter, H., & McCaffrey, N. (2025). Toward a comprehensive research agenda: Exploring the health economics of palliative care in Australia. BMC Palliative Care, 24(1), 276. https://doi.org/10.1186/s12904-025-01867-3